Data for: Cost-Effectiveness Analysis of Maternal Immunisation Against Group B Streptococcus (GBS) Disease: a Modelling Study.
Published: 31 March 2020| Version 1 | DOI: 10.17632/gbhpxc3zgk.1
Contributor:
Kyriaki GiorgakoudiDescription
Deterministic and probabilistic model code developed by Kyriaki Giorgakoudi for investigating the cost-effectiveness of group B streptococcus vaccination. Methodology described in paper: 'Cost-Effectiveness Analysis of Maternal Immunisation Against Group B Streptococcus (GBS) Disease: a Modelling Study' Kyriaki.Giorgakoudi@brunel.ac.uk Institute of Environment, Health and Societies, Brunel University London, London, UK
Files
Categories
Epidemiology, Infectious Disease, Vaccines, Health Economics